| [1] |
Sick PB, Schuler G, Hauptmann KE, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation[J].J Am Coll Cardiol, 2007, 49(13): 1490-1495.
|
| [2] |
Pheerawong P, Songmuang SB, Lertsuwunseri V, et al. Clinical results of left atrial appendage closure with watchman device in patients with atrial fibrillation[J]. J Med Assoc Thai, 2015, 98(10): 942-949.
|
| [3] |
Wiebe J, Franke J, Lehn K, et al. Percutaneous left atrial appendage closure with the watchman device long-term results up to 5 years[J]. JACC Cardiovasc Interv, 2015, 8(15): 1915-1921.
|
| [4] |
Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation:a randomised non-inferiority trial[J].Lancet, 2009, 374(9689): 534-542.
|
| [5] |
姬国华，杨栋，张邢炜，等.16例房颤患者左心耳封堵术的围手术期护理及随访[J].中华全科医学, 2015, 13(11): 1861-1863.
|
| [6] |
吴小三，方传勤.CHADS2评分在非瓣膜病心房颤动患者发生缺血性脑卒中短期预后的预测价值[J].中华老年心脑血管病杂志, 2015, 17(10): 1055-1057.
|
| [7] |
Giralt-Steinhauer E, Cuadrado-Godia E, Ois A, et al. Comparison between CHADS2 and CHA2 DS2-VASc score in a stroke cohort with atrial fibrillation[J]. Eur J Neurol, 2013, 20(4): 623-628.
|
| [8] |
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J]. Ann Intern Med, 2007, 146(12): 857-867.
|
| [9] |
Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience[J]. Circulation, 2002, 105(16): 1887-1889.
|
| [10] |
Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for embolic protection in patients with AF (PROTECT AF) clinical trial and the Continued Access Registry[J]. Circulation, 2011, 123(4): 417-424.
|
| [11] |
Reddy VY, Doshi SK, Sievert H, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial[J]. Circulation, 2013, 127(6): 720-729.
|
| [12] |
Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial[J]. J Am Coll Cardiol, 2014, 64(1): 1-12.
|
| [13] |
肖云云，徐伟，徐标.经皮左心耳封堵术的有效性与安全性[J].医学研究生学报, 2015, 28(5): 553-556.
|
| [14] |
Park JW, Bethencourt A, Sievert H, et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience[J]. Catheter Cardiovasc Interv, 2011, 77(5): 700-706.
|
| [15] |
何璐，张玉顺.经皮左心耳封堵术预防心房颤动血栓栓塞的应用前景[J].心血管病学进展, 2013, 34(5): 604-607.
|
| [16] |
Park J, Sievert H, Omran H, et al. Tct-112 interim data from amplatzer cardiac plug registry[J]. J Am Coll Cardiol, 2011, 58(20): 33-36.
|
| [17] |
姚青，宋治远，舒茂琴，等.Watchman左心耳封堵器的临床应用[J].第三军医大学学报, 2014, 36(20): 2129-2132.
|
| [18] |
杨思共，张恒.经皮左心耳封堵装置预防心房颤动血栓新进展[J].安徽医药, 2017, 21(3): 430-434.
|
| [19] |
Bartus K, Han FT, Bednarek J, et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience[J]. J Am Coll Cardiol, 2013, 62(2): 108-118.
|
| [20] |
Price MJ, Gibson DN, Yakubov SJ, et al. Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium[J]. J Am Coll Cardiol, 2014, 64(6): 565-572.
|
| [21] |
Afzal MR, Kanmanthareddy A, Earnest M, et al. Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices[J]. Heart Rhythm, 2015, 12(1): 52-59.
|
| [22] |
Starck CT, Steffel J, Emmert MY, et al. Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage[J]. Interact Cardiovasc Thorac Surg, 2012, 15(3): 416-418.
|
| [23] |
Di Biase L, Burkhardt JD, Mohanty P, et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio[J]. Circulation, 2010, 121(23): 2550-2556.
|
| [24] |
Kawamura M, Scheinman MM, Lee RJ, et al. Left atrial appendage ligation in patients with atrial fibrillation leads to a decrease in atrial dispersion[J]. J Am Heart Assoc, 2015, 4(5).pii: e001581.
|
| [25] |
Majunke N, Sandri M, Adams V, et al. Atrial and brain natriuretic peptide secretion after percutaneous closure of the left atrial appendage with the Watchman device[J]. J Invasive Cardiol, 2015, 27(10): 448-452.
|
| [26] |
Cruz-Gonzalez I, Palazuelos Molinero J, Valenzuela M, et al. Brain natriuretic peptide levels variation after left atrial appendage occlusion[J]. Catheter Cardiovasc Interv, 2016, 87(1): E39-43.
|
| [27] |
Behnes M, Sartorius B, Wenke A, et al. Percutaneous closure of left atrial appendage affects Mid-Term release of MR-pro ANP[J]. Sci Rep, 2017, 7(1): 9028.
|
| [28] |
Bösche LI, Afshari F, Schöne D, et al. Initial experience with novel oral anticoagulants during the first 45 days after left atrial appendage closure with the Watchman device[J].Clin Crdiola, 2015, 38(12): 720-724.
|
| [29] |
Seeger J, Bothner C, Dahme T, et al. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk[J]. Clin Res Cardiol, 2016, 105(3): 225-229.
|
| [30] |
Bonnet G, Salaun E, Pankert M, et al. Initial experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry[J]. Arch Crdiovasc Dis, 2016, 109(12): 689-695.
|
| [31] |
Wiebe J, Bertog S, Franke J, et al. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation[J]. Catheter Cardiovasc Interv, 2014, 83(5): 796-802.
|
| [32] |
Barakat AF, Hussein AA, Saliba WI, et al. Initial experience with high-risk patients excluded from clinical trials: safety of short-term anticoagulation after left atrial appendage closure device[J]. Circ Arhrythm Electrophysiol, 2016, 9(6).pii: e004004.
|
| [33] |
Fahmy P, Spencer R, Tsang M, et al. Left atrial appendage closure for atrial fibrillation is safe and effective after intracranial or intraocular hemorrhage[J].Can J Cardiol, 2016, 32(3): 349-354.
|
| [34] |
陈涵.左心耳封堵术后用药再起波澜[J].心电与循环, 2017, 36(4): 281.
|